Medical Device Classification Explained: EU, US and GCC

Medical device classification sorts devices into risk classes, and the class decides how much evidence a regulator expects before the device reaches the market. The EU uses classes I, IIa, IIb and III under Regulation (EU) 2017/745 (MDR), the US FDA uses classes I, II and III, and GCC regulators apply risk-based systems built on similar international principles.

Classification is the first regulatory decision for any device: it sets the conformity assessment route, the depth of clinical evidence and the quality system expectations, so a wrong class found late can waste months of work on the wrong pathway.

What drives a device's class

Every system asks similar questions, and the answers come from the manufacturer's intended purpose: what the device does, on whom, for how long and with what claims. The same physical product can land in different classes if the claims change.

• Duration: the MDR defines transient (normally under 60 minutes), short-term (60 minutes to 30 days) and long-term (more than 30 days) use
• Invasiveness: non-invasive, via a body orifice, surgically invasive or implantable
• Active function: whether the device depends on a source of energy such as electricity
• Body site: higher classes for contact with the heart, central circulatory system or central nervous system
• Special features: medicinal substances, animal tissue, nanomaterials or absorption by the body

EU MDR: classes I, IIa, IIb and III

Under the MDR, the manufacturer applies the 22 rules in Annex VIII: non-invasive devices (rules 1 to 4), invasive devices (rules 5 to 8), active devices (rules 9 to 13) and special rules (rules 14 to 22). Where more than one rule applies, the strictest rule and highest class apply. Guidance MDCG 2021-24 gives examples for each rule.

Class I devices are generally self-declared, but sterile (Is), measuring (Im) and reusable surgical (Ir) class I devices need a notified body for those aspects. Class IIa, IIb and III devices all need notified body involvement, with review depth and clinical evidence increasing by class. Software falls under rule 11, which places much decision-support software in class IIa or higher.

IVDs follow a separate EU regulation

In vitro diagnostic devices are not classified under the MDR. They fall under Regulation (EU) 2017/746 (IVDR), which uses classes A, B, C and D set by seven rules in its own Annex VIII. Class D covers the highest public health risk, such as tests for transmissible agents in blood for transfusion.

US FDA: classes I, II and III

Rather than applying rules, a US manufacturer finds the existing classification regulation for its device type in 21 CFR Parts 862 to 892, organised by specialty panel, and the matching product code in the FDA product classification database.

• Class I: lowest risk, general controls such as registration, listing, labelling and quality system requirements; most are exempt from premarket notification
• Class II: moderate risk, general and special controls; most need a 510(k) showing substantial equivalence to a legally marketed predicate
• Class III: highest risk, often life-sustaining or implantable; most need premarket approval (PMA) supported by valid scientific evidence, usually including clinical data

For a novel low-to-moderate risk device with no suitable predicate, the De Novo pathway lets FDA create a new classification. Unlike the EU, the US classifies IVDs within the same class I, II and III system.

GCC: SFDA, the UAE and other authorities

In Saudi Arabia, the Saudi Food and Drug Authority (SFDA) classifies devices with a risk-based system broadly aligned with principles from the Global Harmonization Task Force (GHTF) and its successor, the International Medical Device Regulators Forum (IMDRF). GHTF guidance groups general devices from class A (lowest risk) to class D (highest). SFDA publishes its own classification guidance and submission requirements, which are revised from time to time, so check the current documents before planning a submission.

In the UAE, devices must be registered with the federal authority responsible for medical products before marketing. This has historically been the Ministry of Health and Prevention (MOHAP), and the Emirates Drug Establishment has since been created to regulate medical products, so confirm which body handles your product. Oman, Qatar, Kuwait and Bahrain run their own systems, and foreign manufacturers usually need a local authorised representative or registered distributor.

Typical classes by region

These are typical outcomes for standard intended purposes; the actual class depends on the product, its claims and current rules.

Classes do not translate one to one. US class II covers devices the EU places in IIa or IIb, so classify separately for each market.

Worked example: a Sharjah start-up with a wound dressing

A small Sharjah start-up has developed a sterile, single-use foam dressing for sale first in the UAE and Saudi Arabia, then the EU. Its first intended purpose statement claimed the dressing promotes healing of chronic diabetic foot ulcers.

1. Write the intended purpose precisely: a sterile foam dressing that absorbs exudate and maintains a moist environment for superficial, moderately exuding wounds.
2. Apply EU rule 4: dressings acting as a mechanical barrier or absorbing exudate are class I; those principally managing the wound micro-environment are generally IIa; those intended mainly for wounds that breach the dermis and heal only by secondary intent, such as chronic ulcers, are IIb.
3. Check the special rules: for a planned silver version, rule 14 applies if the silver is a medicinal substance with ancillary action, making it class III.
4. Remember sterility: even the class I version is class Is, so a notified body reviews sterilisation.
5. Map other markets: identify the FDA product code, check current SFDA and UAE requirements and record the rule and rationale for each.

The plain dressing launched with claims limited to exudate management and a moist wound environment, with the rationale documented in the technical file. The silver version and the ulcer claim moved to a later programme with its own clinical evidence plan.

Common mistakes

• Classifying the physical product instead of its intended purpose and claims
• Adding a marketing claim that moves the device into a higher class
• Assuming a US class maps directly to an EU or GCC class
• Forgetting that sterile, measuring and reusable surgical class I devices need a notified body
• Treating an IVD as a general device under the MDR
• Leaving the rule-by-rule rationale out of the technical documentation

Key takeaway: Classification follows the intended purpose and claims, not the product itself. Write the intended purpose first, apply each region's rules in writing and confirm current requirements with the authority before committing to a pathway.

Frequently Asked Questions

What are the four classes of medical devices in the EU?

Under the EU MDR, general medical devices are class I, IIa, IIb or III, in increasing order of risk. The class is set by the Annex VIII rules, based on duration of use, invasiveness, active function and the part of the body affected. Sterile, measuring and reusable surgical class I devices need limited notified body review.

What is the difference between a 510(k) and a PMA?

A 510(k) is a premarket notification showing that a device is substantially equivalent to a legally marketed predicate, and it is the usual route for class II devices. Premarket approval (PMA) is the more demanding route for most class III devices, requiring valid scientific evidence, usually including clinical data, of safety and effectiveness.

Who decides the class of a medical device?

The manufacturer proposes the class by applying the rules and documenting its reasoning. In the EU, a notified body reviews that reasoning for the devices it assesses, and disputes can go to the national competent authority. In the US, classification comes from FDA regulations and product codes, and manufacturers can ask FDA for its view through a 513(g) request.

Does the GCC follow EU medical device classes?

Not directly. SFDA uses a risk-based system broadly aligned with GHTF and IMDRF principles, so results often resemble the EU outcome, but its own rules decide the class. Other GCC requirements are set by each national authority. Confirm with the regulator rather than assuming an EU or US class transfers unchanged.

Next steps

For a structured route through GCC submissions and device quality systems, explore Regulatory Affairs for Pharma & Medical Devices in the GCC and Medical Device Quality Management (ISO 13485). Innoryx delivers both online to learners in India and the GCC.

Then read ISO 13485 vs ISO 9001, pharmaceutical product registration in the UAE and Saudi Arabia and IQ, OQ and PQ qualification explained, or speak to a counsellor.